U.S. Telemedicine Market Size By Service, By Type, By Specialty, By Component, By Delivery Mode, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023

Description

List of Tables

U.S. Telemedicine Market is poised to grow at a significant rate through 2032, owing to the technological advancements around internet and mobile phones. Besides, there is an increasing investment by venture capitalists in this field, owing to the excellent return-on-investments and massive growth opportunities, which will also add impetus to the market.

In addition, favorable government initiatives are also contributing to the market growth. To cite an instance, in December 2022, Planned Parenthood, which is an affiliate of the U.S. reproductive health department, announced introducing teleconference facilities at one of its clinics in Kansas City, along with the assistance of off-site doctors to help patients seeking medical abortions.

Overall, the U.S. telemedicine market has been divided in terms of service, type, specialty, component, and delivery mode.

On the basis of service, the tele-monitoring system will grow significantly between 2023 and 2032, as tele-monitoring systems can examine various illnesses such as cardiopulmonary disease, asthma, and heart failure. Building on the aforesaid, studies have proven that telemonitoring can be effective in the treatment of heart diseases. For instance, in December 2021, research published in in the Annals of Palliative Medicine concluded that in the context of health care for patients suffering from cardiovascular disorders, the intervention of telemedicine has proven to be helpful.

In terms of specialty, the U.S. telemedicine market is likely to be characterized by the neurology segment, which will grow at more than 13% CAGR between 2023 and 2032. Telemedicine has a wide range of applications and is used for treating dementia, epilepsy, neuropathology, and tremors, which will fuel the market expansion. Besides, the segment gained significant traction during Covid-19 pandemic, where neurologists used telemedicine to treat their patients. Studies depict that video links and telephones have been used to treat patients suffering from amyotrophic lateral sclerosis and Parkinson's disease.

In the context of the component, the hardware segment accounted for more than USD 5.3 billion in 2022 and will grow steadily between 2023 and 2032. The segmental growth will be attributed to the increasing use of devices such as digital cameras, telemedicine carts, and laptops.

Based on the delivery mode, the web/mobile segment will witness robust growth within the next ten years, owing to the growing demand for fast-speed internet and rising investment in telecommunication infrastructure. According a reliable source, with more than 307 million internet users, the U.S.A ranks third and is among the third largest online market in the world. Such trends are poised to push the product demand in the future.

Product Code: 4362

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope & definition
1.3 Base estimates & working
- 1.3.1 North America
- 1.3.2 Europe
- 1.3.3 Asia Pacific
- 1.3.4 Latin America
- 1.3.5 MEA
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Secondary
  - 1.6.1.1 Paid sources
  - 1.6.1.2 Unpaid sources
- 1.6.2 Primary

Chapter 2 Executive Summary

2.1 U.S. telemedicine industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends

Chapter 3 US Telemedicine Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing prevalence of chronic diseases
  - 3.3.1.2 Growing number of smartphone users
  - 3.3.1.3 Technological advancements related to mobile phones and internet
  - 3.3.1.4 Long waiting time in hospitals for disease treatment
  - 3.3.1.5 Favorable government initiatives
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Security and privacy concerns
  - 3.3.2.2 Stringent regulatory policies and limited reimbursement in the U.S.
3.4 Growth potential analysis
- 3.4.1 By service
- 3.4.2 By type
- 3.4.3 By specialty
- 3.4.4 By component
- 3.4.5 By delivery mode
3.5 COVID-19 impact analysis
3.6 Penetration/adoption in U.S. hospitals
3.7 Reimbursement scenario in U.S.
3.8 Telemedicine modalities
3.9 Government initiatives
- 3.9.1 U.S. Department of Agriculture (USDA) Initiative
- 3.9.2 Rural Health Care (RHC) Program
- 3.9.3 U.S. Department of Defense Initiative
3.10 Telemedicine future trends
3.11 Porter's analysis
- 3.11.1 Industry rivalry
- 3.11.2 Bargaining power of suppliers
- 3.11.3 Bargaining power of buyers
- 3.11.4 Threat of substitute
- 3.11.5 Threat of new entrants
3.12 PESTEL analysis
- 3.12.1 Political
- 3.12.2 Economical
- 3.12.3 Social
- 3.12.4 Technological
- 3.12.5 Legal
- 3.12.6 Environmental

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Competitive analysis of major players
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 US Telemedicine Market, By Service

5.1 Key segment trends
5.2 Tele-consulting
- 5.2.1 Market size, 2018 - 2032 (USD Million)
5.3 Tele-monitoring
- 5.3.1 Market size, 2018 - 2032 (USD Million)
5.4 Tele-education/training
- 5.4.1 Market size, 2018 - 2032 (USD Million)
5.5 Others
- 5.5.1 Market size, 2018 - 2032 (USD Million)

Chapter 6 US Telemedicine Market, By Type

6.1 Key segment trends
6.2 Telehospital
- 6.2.1 Market size, 2018 - 2032 (USD Million)
- 6.2.2 Integrated delivery network (IDN)
  - 6.2.2.1 Market size, 2018 - 2032 (USD Million)
- 6.2.3 Academic medical center (AMC)
  - 6.2.3.1 Market size, 2018 - 2032 (USD Million)
- 6.2.4 Large independent hospitals
  - 6.2.4.1 Market size, 2018 - 2032 (USD Million)
- 6.2.5 Medium independent hospitals
  - 6.2.5.1 Market size, 2018 - 2032 (USD Million)
- 6.2.6 Small hospitals
  - 6.2.6.1 Market size, 2018 - 2032 (USD Million)
- 6.2.7 Others
  - 6.2.7.1 Market size, 2018 - 2032 (USD Million)
6.3 Telehome
- 6.3.1 Market size, 2018 - 2032 (USD Million)

Chapter 7 US Telemedicine Market, By Specialty

7.1 Key segment trends
7.2 Cardiology
- 7.2.1 Market size, 2018 - 2032 (USD Million)
7.3 Gynecology
- 7.3.1 Market size, 2018 - 2032 (USD Million)
7.4 Neurology
- 7.4.1 Market size, 2018 - 2032 (USD Million)
7.5 Orthopedics
- 7.5.1 Market size, 2018 - 2032 (USD Million)
7.6 Dermatology
- 7.6.1 Market size, 2018 - 2032 (USD Million)
7.7 Metal health
- 7.7.1 Market size, 2018 - 2032 (USD Million)
7.8 Critical care
- 7.8.1 Market size, 2018 - 2032 (USD Million)
7.9 Neonatology
- 7.9.1 Market size, 2018 - 2032 (USD Million)
7.10 Others
- 7.10.1 Market size, 2018 - 2032 (USD Million)

Chapter 8 US Telemedicine Market, By Component

8.1 Key segment trends
8.2 Hardware
- 8.2.1 Market size, 2018 - 2032 (USD Million)
8.3 Software
- 8.3.1 Market size, 2018 - 2032 (USD Million)
8.4 Services
- 8.4.1 Market size, 2018 - 2032 (USD Million)

Chapter 9 US Telemedicine Market, By Delivery Mode

9.1 Key segment trends
9.2 Web/Mobile
- 9.2.1 Market size, 2018 - 2032 (USD Million)
- 9.2.2 Telephonic
  - 9.2.2.1 Market size, 2018 - 2032 (USD Million)
- 9.2.3 Visualized
  - 9.2.3.1 Market size, 2018 - 2032 (USD Million)
9.3 Call Centers
- 9.3.1 Market size, 2018 - 2032 (USD Million)

Chapter 10 Company Profiles

10.1 Allscripts Healthcare Solutions Inc
- 10.1.1 Business overview
- 10.1.2 Financial data
- 10.1.3 Product landscape
- 10.1.4 Strategic outlook
- 10.1.5 SWOT analysis
10.2 AMD Global Telemedicine, Inc.
- 10.2.1 Business overview
- 10.2.2 Financial data
- 10.2.3 Product landscape
- 10.2.4 Strategic outlook
- 10.2.5 SWOT analysis
10.3 American Well
- 10.3.1 Business overview
- 10.3.2 Financial data
- 10.3.3 Product landscape
- 10.3.4 Strategic outlook
- 10.3.5 SWOT analysis
10.4 Oracle Corporation (Cerner)
- 10.4.1 Business overview
- 10.4.2 Financial data
- 10.4.3 Product landscape
- 10.4.4 Strategic outlook
- 10.4.5 SWOT analysis
10.5 Cisco
- 10.5.1 Business overview
- 10.5.2 Financial data
- 10.5.3 Product landscape
- 10.5.4 Strategic outlook
- 10.5.5 SWOT analysis
10.6 Eagle Telemedicine
- 10.6.1 Business overview
- 10.6.2 Financial data
- 10.6.3 Product landscape
- 10.6.4 Strategic outlook
- 10.6.5 SWOT analysis
10.7 Honeywell International Inc.
- 10.7.1 Business overview
- 10.7.2 Financial data
- 10.7.3 Product landscape
- 10.7.4 Strategic outlook
- 10.7.5 SWOT analysis
10.8 Koninklijke Philips N.V.
- 10.8.1 Business overview
- 10.8.2 Financial data
- 10.8.3 Product landscape
- 10.8.4 Strategic outlook
- 10.8.5 SWOT analysis
10.9 McKesson Corporation
- 10.9.1 Business overview
- 10.9.2 Financial data
- 10.9.3 Product landscape
- 10.9.4 Strategic outlook
- 10.9.5 SWOT analysis
10.10 OBS Medical
- 10.10.1 Business overview
- 10.10.2 Financial data
- 10.10.3 Product landscape
- 10.10.4 Strategic outlook
- 10.10.5 SWOT analysis
10.11 SOC Telemed
- 10.11.1 Business overview
- 10.11.2 Financial data
- 10.11.3 Product landscape
- 10.11.4 Strategic outlook
- 10.11.5 SWOT analysis
10.12 Specialist Telemed
- 10.12.1 Business overview
- 10.12.2 Financial data
- 10.12.3 Product landscape
- 10.12.4 Strategic outlook
- 10.12.5 SWOT analysis
10.13 Teladoc Health
- 10.13.1 Business overview
- 10.13.2 Financial data
- 10.13.3 Product landscape
- 10.13.4 Strategic outlook
- 10.13.5 SWOT analysis